These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14763357)

  • 1. [Risk factors for upper digestive tract toxicity with NSAIDs (excluding Helicobacter pylori)].
    Lamarque D; Chaussade S
    Presse Med; 2003 Nov; 32(37 Pt 2):S56-9. PubMed ID: 14763357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
    Laine L
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety of selective cyclooxygenase-2 inhibitors taken for a long time].
    Lamarque D
    Bull Cancer; 2004 May; 91 Suppl 2():S117-24. PubMed ID: 15899636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The epidemiology of the gastroduodenal damage induced by aspirin and other nonsteroidal anti-inflammatory drugs].
    Dobrilla G; Benvenuti S; de Guelmi A
    Recenti Prog Med; 1997 May; 88(5):202-11. PubMed ID: 9244954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of non-steroidal anti-inflammatory drug damage to stomach and duodenum.
    Langman MJ
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S2-5. PubMed ID: 10379462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.
    Chen TS; Luo JC; Chang FY
    J Gastroenterol Hepatol; 2010 May; 25(5):919-22. PubMed ID: 20074147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features and diagnosis of non-steroidal anti-inflammatory drugs induced ulcers of the stomach].
    Watari J; Kim Y; Yokoyama S; Hori K; Miwa H
    Nihon Rinsho; 2011 Jun; 69(6):1016-23. PubMed ID: 21688621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
    Karateev AE; Nasonova VA
    Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ulcer and bleeding complications and their relationship with dyspeptic symptoms in NSAIDs users: a transversal multicenter study.
    Dib RA; Chinzon D; Fontes LH; de Sá Teixeira AC; Navarro-Rodriguez T
    Scand J Gastroenterol; 2014 Jul; 49(7):785-9. PubMed ID: 24941264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in managing NSAID-associated gastrointestinal tract injury.
    Goldstein JL
    Digestion; 2004; 69 Suppl 1():25-33. PubMed ID: 15001832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological aspects of NSAID gastropathy.
    Guslandi M
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():6-8. PubMed ID: 9032573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making.
    Hansen JM; Hallas J; Lauritsen JM; Bytzer P
    Scand J Gastroenterol; 1996 Feb; 31(2):126-30. PubMed ID: 8658033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan.
    Hsiang KW; Chen TS; Lin HY; Luo JC; Lu CL; Lin HC; Lee KC; Chang FY; Lee SD
    Clin Ther; 2010 Jul; 32(7):1294-303. PubMed ID: 20678677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
    Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
    Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population.
    García Rodríguez LA; Barreales Tolosa L
    Gastroenterology; 2007 Feb; 132(2):498-506. PubMed ID: 17258728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insight into the mechanisms of gastroduodenal injury induced by nonsteroidal anti-inflammatory drugs: practical implications.
    Kwiecień S; Magierowska K; Śliwowski Z; Wójcik D; Magierowski M; Brzozowski T
    Pol Arch Med Wewn; 2015; 125(3):191-8. PubMed ID: 25666703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.